Use of a novel aminopyridine derivative to prevent or treat cancer
US9206132B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2014 |
| Grant date | Dec 8, 2015 |
| Priority date | — |
| Expiry date | Oct 20, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aminopyridine derivative of Formula 1 and a method of preventing or treating cancer using the same. Formula 1:In Formula 1: X1 and X2 are each independently selected from the group consisting of carbon and nitrogen; R1 to R5 are each independently selected from the group consisting of a hydrogen, a straight, a branched, or cyclo alkyl of C1-C4, a halogen, and a hydroxyl; and R6 is a hydrogen or an alkyl of C1-C6.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.